

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.13261911 |
| 2 | ethanol oxidation (GO:0006069) | 5.79642993 |
| 3 | exogenous drug catabolic process (GO:0042738) | 5.70316152 |
| 4 | drug catabolic process (GO:0042737) | 5.64495292 |
| 5 | angiotensin maturation (GO:0002003) | 5.59157539 |
| 6 | urea metabolic process (GO:0019627) | 5.16944121 |
| 7 | complement activation, alternative pathway (GO:0006957) | 5.15367514 |
| 8 | drug metabolic process (GO:0017144) | 5.12954889 |
| 9 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.05821123 |
| 10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.98137933 |
| 11 | ethanol metabolic process (GO:0006067) | 4.88517334 |
| 12 | urea cycle (GO:0000050) | 4.86014580 |
| 13 | complement activation, classical pathway (GO:0006958) | 4.83682694 |
| 14 | cellular glucuronidation (GO:0052695) | 4.79923488 |
| 15 | nitrogen cycle metabolic process (GO:0071941) | 4.76089842 |
| 16 | regulation of protein activation cascade (GO:2000257) | 4.75816106 |
| 17 | glucuronate metabolic process (GO:0019585) | 4.68130123 |
| 18 | uronic acid metabolic process (GO:0006063) | 4.68130123 |
| 19 | omega-hydroxylase P450 pathway (GO:0097267) | 4.67112331 |
| 20 | regulation of complement activation (GO:0030449) | 4.63728558 |
| 21 | intestinal absorption (GO:0050892) | 4.56537948 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 4.54810127 |
| 23 | complement activation (GO:0006956) | 4.47219238 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.26829109 |
| 25 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.24752346 |
| 26 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.24752346 |
| 27 | phospholipid efflux (GO:0033700) | 4.14742264 |
| 28 | NADH metabolic process (GO:0006734) | 4.14381357 |
| 29 | bile acid and bile salt transport (GO:0015721) | 4.14332721 |
| 30 | protein activation cascade (GO:0072376) | 4.09720370 |
| 31 | regulation of fibrinolysis (GO:0051917) | 4.07540368 |
| 32 | fructose metabolic process (GO:0006000) | 4.06589233 |
| 33 | hormone catabolic process (GO:0042447) | 4.01069106 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 3.95825082 |
| 35 | macromolecular complex remodeling (GO:0034367) | 3.95825082 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 3.95825082 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 3.93336108 |
| 38 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.92670846 |
| 39 | bile acid metabolic process (GO:0008206) | 3.90398997 |
| 40 | acute-phase response (GO:0006953) | 3.87913993 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 3.85915028 |
| 42 | negative regulation of sterol transport (GO:0032372) | 3.76728139 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 3.76728139 |
| 44 | glyoxylate metabolic process (GO:0046487) | 3.75479590 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.72787240 |
| 46 | L-phenylalanine metabolic process (GO:0006558) | 3.72787240 |
| 47 | flavonoid metabolic process (GO:0009812) | 3.72367583 |
| 48 | L-phenylalanine catabolic process (GO:0006559) | 3.71500038 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.71500038 |
| 50 | regulation of guanylate cyclase activity (GO:0031282) | 3.71329853 |
| 51 | regulation of bile acid biosynthetic process (GO:0070857) | 3.70343598 |
| 52 | arginine metabolic process (GO:0006525) | 3.66102481 |
| 53 | phenylpropanoid metabolic process (GO:0009698) | 3.59412480 |
| 54 | plasma lipoprotein particle assembly (GO:0034377) | 3.59364544 |
| 55 | diacylglycerol metabolic process (GO:0046339) | 3.59303156 |
| 56 | primary alcohol catabolic process (GO:0034310) | 3.56615501 |
| 57 | alkaloid metabolic process (GO:0009820) | 3.56286453 |
| 58 | fibrinolysis (GO:0042730) | 3.53135444 |
| 59 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.50504569 |
| 60 | regulation of cellular extravasation (GO:0002691) | 3.48569280 |
| 61 | high-density lipoprotein particle remodeling (GO:0034375) | 3.48547289 |
| 62 | lipoprotein transport (GO:0042953) | 3.48445862 |
| 63 | low-density lipoprotein particle remodeling (GO:0034374) | 3.47997113 |
| 64 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.45504225 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 3.45503832 |
| 66 | cholesterol efflux (GO:0033344) | 3.41767501 |
| 67 | lipoprotein metabolic process (GO:0042157) | 3.40822858 |
| 68 | plasma lipoprotein particle organization (GO:0071827) | 3.37800879 |
| 69 | renal system process involved in regulation of blood volume (GO:0001977) | 3.36135419 |
| 70 | negative regulation of hemostasis (GO:1900047) | 3.34916561 |
| 71 | negative regulation of blood coagulation (GO:0030195) | 3.34916561 |
| 72 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.33645043 |
| 73 | protein carboxylation (GO:0018214) | 3.33645043 |
| 74 | protein-lipid complex assembly (GO:0065005) | 3.29386103 |
| 75 | protein-lipid complex subunit organization (GO:0071825) | 3.22755890 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.19436983 |
| 77 | regulation of humoral immune response (GO:0002920) | 3.17524731 |
| 78 | bile acid biosynthetic process (GO:0006699) | 3.15454665 |
| 79 | adhesion of symbiont to host cell (GO:0044650) | 3.13487563 |
| 80 | virion attachment to host cell (GO:0019062) | 3.13487563 |
| 81 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.12951080 |
| 82 | negative regulation of coagulation (GO:0050819) | 3.12692511 |
| 83 | regulation of vitamin metabolic process (GO:0030656) | 3.09757721 |
| 84 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.08420596 |
| 85 | endocrine process (GO:0050886) | 3.08420596 |
| 86 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.08420596 |
| 87 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.07755382 |
| 88 | primary alcohol metabolic process (GO:0034308) | 3.00494409 |
| 89 | aromatic amino acid family catabolic process (GO:0009074) | 2.98288516 |
| 90 | positive regulation of pseudopodium assembly (GO:0031274) | 2.96071487 |
| 91 | acylglycerol homeostasis (GO:0055090) | 2.94714423 |
| 92 | triglyceride homeostasis (GO:0070328) | 2.94714423 |
| 93 | negative regulation of wound healing (GO:0061045) | 2.94360502 |
| 94 | positive regulation of respiratory burst (GO:0060267) | 2.89897472 |
| 95 | antimicrobial humoral response (GO:0019730) | 2.89325569 |
| 96 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.88634380 |
| 97 | xenobiotic metabolic process (GO:0006805) | 2.87696170 |
| 98 | glycosphingolipid catabolic process (GO:0046479) | 2.85516988 |
| 99 | acute inflammatory response (GO:0002526) | 2.85373153 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 2.85297370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.26441352 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17147768 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.63262868 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.52099416 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.46362429 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.43231352 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.38015610 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.32032055 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.16418435 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.95781653 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70052769 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.60205364 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18424618 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.16904656 |
| 15 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.12224041 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.00248005 |
| 17 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.93819968 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93471167 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.92064111 |
| 20 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.83148365 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.81961930 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79626551 |
| 23 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.79464669 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.76759721 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63854410 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.63159950 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63128599 |
| 28 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.59587269 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58674953 |
| 30 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52373782 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52249567 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47823236 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.47073151 |
| 34 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.40192939 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37221699 |
| 36 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.36559551 |
| 37 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.36066796 |
| 38 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34594647 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33400842 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27453588 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26123169 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23548975 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22136801 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22115457 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19802639 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16278856 |
| 47 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15674204 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.14706326 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14076064 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13365886 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13298093 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11486269 |
| 53 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10645544 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10205527 |
| 55 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10170306 |
| 56 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08787702 |
| 57 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06538214 |
| 58 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05288730 |
| 59 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04049413 |
| 60 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.02095899 |
| 61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00388104 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00317087 |
| 63 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99389574 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98939192 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98665303 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98600599 |
| 67 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95822738 |
| 68 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93804419 |
| 69 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92295518 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92069834 |
| 71 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91611123 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.90942659 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90073830 |
| 74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89771701 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89631429 |
| 76 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88482789 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.87669434 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86350538 |
| 79 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85210705 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83956276 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.83815316 |
| 82 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.83289620 |
| 83 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.83110902 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.82847153 |
| 85 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.81631243 |
| 86 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.81535805 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.81181904 |
| 88 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.79539812 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79462597 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78986986 |
| 91 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.78016087 |
| 92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74379838 |
| 93 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.74186178 |
| 94 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.74070327 |
| 95 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.73053040 |
| 96 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.72994307 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72481285 |
| 98 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.72349236 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 0.72203529 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71928916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.33648367 |
| 2 | MP0005360_urolithiasis | 6.75891088 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.65288869 |
| 4 | MP0005365_abnormal_bile_salt | 4.34586576 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.91060066 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.34342418 |
| 7 | MP0009840_abnormal_foam_cell | 3.26052364 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.56654101 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 2.55090570 |
| 10 | MP0010155_abnormal_intestine_physiology | 2.48321439 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.34119279 |
| 12 | MP0003252_abnormal_bile_duct | 2.23671624 |
| 13 | MP0003195_calcinosis | 2.23354519 |
| 14 | MP0003868_abnormal_feces_composition | 2.17556808 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.05233995 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.04745135 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.00499920 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.98716780 |
| 19 | MP0003303_peritoneal_inflammation | 1.96142455 |
| 20 | MP0005332_abnormal_amino_acid | 1.89582379 |
| 21 | MP0009379_abnormal_foot_pigmentation | 1.71767561 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.69736262 |
| 23 | MP0009785_altered_susceptibility_to | 1.68476585 |
| 24 | MP0005166_decreased_susceptibility_to | 1.67114187 |
| 25 | MP0005451_abnormal_body_composition | 1.61724514 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.58380240 |
| 27 | MP0001764_abnormal_homeostasis | 1.49586149 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.48413530 |
| 29 | MP0004264_abnormal_extraembryonic_tissu | 1.47737544 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.46002833 |
| 31 | MP0000609_abnormal_liver_physiology | 1.45599555 |
| 32 | MP0003436_decreased_susceptibility_to | 1.39413572 |
| 33 | MP0003866_abnormal_defecation | 1.35644382 |
| 34 | MP0003724_increased_susceptibility_to | 1.34589079 |
| 35 | MP0009764_decreased_sensitivity_to | 1.32056727 |
| 36 | MP0006082_CNS_inflammation | 1.30866640 |
| 37 | MP0000604_amyloidosis | 1.25412096 |
| 38 | MP0005025_abnormal_response_to | 1.22698712 |
| 39 | MP0003075_altered_response_to | 1.20020706 |
| 40 | MP0008469_abnormal_protein_level | 1.19332113 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.18144346 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.17727879 |
| 43 | MP0005387_immune_system_phenotype | 1.16184504 |
| 44 | MP0001790_abnormal_immune_system | 1.16184504 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.14622016 |
| 46 | MP0001663_abnormal_digestive_system | 1.14416839 |
| 47 | MP0004043_abnormal_pH_regulation | 1.13828788 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.11287168 |
| 49 | MP0003879_abnormal_hair_cell | 1.08656092 |
| 50 | MP0001664_abnormal_digestion | 1.08636672 |
| 51 | MP0004782_abnormal_surfactant_physiolog | 1.07193112 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.06658619 |
| 53 | MP0001835_abnormal_antigen_presentation | 1.06502583 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.05098713 |
| 55 | MP0002136_abnormal_kidney_physiology | 1.01402257 |
| 56 | MP0000678_abnormal_parathyroid_gland | 0.99459966 |
| 57 | MP0005409_darkened_coat_color | 0.98819608 |
| 58 | MP0000490_abnormal_crypts_of | 0.98307974 |
| 59 | MP0001873_stomach_inflammation | 0.97144740 |
| 60 | MP0004147_increased_porphyrin_level | 0.96325392 |
| 61 | MP0000477_abnormal_intestine_morphology | 0.95232774 |
| 62 | MP0004858_abnormal_nervous_system | 0.94801262 |
| 63 | MP0001765_abnormal_ion_homeostasis | 0.94143825 |
| 64 | MP0001533_abnormal_skeleton_physiology | 0.90041709 |
| 65 | MP0005381_digestive/alimentary_phenotyp | 0.88420516 |
| 66 | MP0002971_abnormal_brown_adipose | 0.87852603 |
| 67 | MP0005535_abnormal_body_temperature | 0.85180957 |
| 68 | MP0002419_abnormal_innate_immunity | 0.82978051 |
| 69 | MP0009763_increased_sensitivity_to | 0.82515980 |
| 70 | MP0003300_gastrointestinal_ulcer | 0.82442036 |
| 71 | MP0009642_abnormal_blood_homeostasis | 0.80912291 |
| 72 | MP0005670_abnormal_white_adipose | 0.80130023 |
| 73 | MP0000249_abnormal_blood_vessel | 0.79683825 |
| 74 | MP0001756_abnormal_urination | 0.78766003 |
| 75 | MP0002132_abnormal_respiratory_system | 0.77470815 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.77062005 |
| 77 | MP0005671_abnormal_response_to | 0.74771851 |
| 78 | MP0005448_abnormal_energy_balance | 0.74354676 |
| 79 | MP0004947_skin_inflammation | 0.72875445 |
| 80 | MP0005165_increased_susceptibility_to | 0.72726544 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 0.72588165 |
| 82 | MP0000685_abnormal_immune_system | 0.72375297 |
| 83 | MP0001800_abnormal_humoral_immune | 0.71661193 |
| 84 | MP0003329_amyloid_beta_deposits | 0.70614106 |
| 85 | MP0004510_myositis | 0.70154890 |
| 86 | MP0008004_abnormal_stomach_pH | 0.65156149 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.64604187 |
| 88 | MP0002796_impaired_skin_barrier | 0.63846449 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.62744734 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.61896844 |
| 91 | MP0002998_abnormal_bone_remodeling | 0.61243834 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.60809676 |
| 93 | MP0005023_abnormal_wound_healing | 0.60583149 |
| 94 | MP0009115_abnormal_fat_cell | 0.59046934 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.58881822 |
| 96 | MP0002723_abnormal_immune_serum | 0.58555294 |
| 97 | MP0001501_abnormal_sleep_pattern | 0.57419487 |
| 98 | MP0005164_abnormal_response_to | 0.56971619 |
| 99 | MP0000598_abnormal_liver_morphology | 0.55940952 |
| 100 | MP0000858_altered_metastatic_potential | 0.55638144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.42647569 |
| 2 | Complement deficiency (HP:0004431) | 7.02075186 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.94971102 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.63687491 |
| 5 | Abnormality of complement system (HP:0005339) | 5.97225504 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.43351064 |
| 7 | Glomerulonephritis (HP:0000099) | 5.10744090 |
| 8 | Malnutrition (HP:0004395) | 4.87724089 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.74364621 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.41152837 |
| 11 | Xanthomatosis (HP:0000991) | 4.26877978 |
| 12 | Hydroxyprolinuria (HP:0003080) | 4.04055276 |
| 13 | Abnormality of proline metabolism (HP:0010907) | 4.04055276 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.95399974 |
| 15 | Fat malabsorption (HP:0002630) | 3.74791830 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 3.73454001 |
| 17 | Nephritis (HP:0000123) | 3.72478512 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.38862863 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36310724 |
| 20 | Hemorrhage of the eye (HP:0011885) | 3.30892707 |
| 21 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.11385722 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.11110274 |
| 23 | Joint hemorrhage (HP:0005261) | 3.03408778 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 3.01703750 |
| 25 | Hyperactive renin-angiotensin system (HP:0000841) | 2.91568321 |
| 26 | Widely patent fontanelles and sutures (HP:0004492) | 2.88380599 |
| 27 | Alkalosis (HP:0001948) | 2.87519757 |
| 28 | Hyperammonemia (HP:0001987) | 2.84879919 |
| 29 | Steatorrhea (HP:0002570) | 2.77704793 |
| 30 | Abnormality of vitamin metabolism (HP:0100508) | 2.76968628 |
| 31 | Chronic diarrhea (HP:0002028) | 2.75309147 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 2.65793687 |
| 33 | Decreased circulating renin level (HP:0003351) | 2.63289049 |
| 34 | Purpura (HP:0000979) | 2.61205228 |
| 35 | Nausea (HP:0002018) | 2.60458309 |
| 36 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.55471542 |
| 37 | Ileus (HP:0002595) | 2.49877319 |
| 38 | Nasal polyposis (HP:0100582) | 2.45563622 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.44597274 |
| 40 | Abnormality of glycine metabolism (HP:0010895) | 2.44597274 |
| 41 | Eczematoid dermatitis (HP:0000976) | 2.42086115 |
| 42 | Glycosuria (HP:0003076) | 2.38849625 |
| 43 | Abnormality of urine glucose concentration (HP:0011016) | 2.38849625 |
| 44 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.38287745 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.35775361 |
| 46 | Hypophosphatemia (HP:0002148) | 2.34971337 |
| 47 | Hyperglycinuria (HP:0003108) | 2.32953674 |
| 48 | Abnormality of vitamin B metabolism (HP:0004340) | 2.28658194 |
| 49 | Abdominal distention (HP:0003270) | 2.25911936 |
| 50 | Generalized aminoaciduria (HP:0002909) | 2.17315443 |
| 51 | Pancreatitis (HP:0001733) | 2.16914976 |
| 52 | Proximal tubulopathy (HP:0000114) | 2.12136188 |
| 53 | Confusion (HP:0001289) | 2.10774640 |
| 54 | Rickets (HP:0002748) | 2.10141668 |
| 55 | Abnormality of the common coagulation pathway (HP:0010990) | 2.09971298 |
| 56 | Amyloidosis (HP:0011034) | 2.09255163 |
| 57 | Spontaneous abortion (HP:0005268) | 2.08228760 |
| 58 | Acanthocytosis (HP:0001927) | 2.06763524 |
| 59 | Epidermoid cyst (HP:0200040) | 2.06544246 |
| 60 | Metabolic acidosis (HP:0001942) | 2.05293203 |
| 61 | Abnormality of renin-angiotensin system (HP:0000847) | 2.05236953 |
| 62 | Cerebral palsy (HP:0100021) | 2.05202165 |
| 63 | Thin bony cortex (HP:0002753) | 2.04624104 |
| 64 | Nephrolithiasis (HP:0000787) | 2.04567715 |
| 65 | Metabolic alkalosis (HP:0200114) | 2.03398156 |
| 66 | Vascular calcification (HP:0004934) | 2.02124683 |
| 67 | Pigmentary retinal degeneration (HP:0001146) | 2.02007357 |
| 68 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.01965823 |
| 69 | Wide cranial sutures (HP:0010537) | 2.01322864 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.01120613 |
| 71 | Hypotension (HP:0002615) | 1.99883866 |
| 72 | Potter facies (HP:0002009) | 1.96124491 |
| 73 | Facial shape deformation (HP:0011334) | 1.96124491 |
| 74 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.93998997 |
| 75 | Irritability (HP:0000737) | 1.93273673 |
| 76 | Protuberant abdomen (HP:0001538) | 1.92483111 |
| 77 | Hyperuricemia (HP:0002149) | 1.91782945 |
| 78 | Increased purine levels (HP:0004368) | 1.91782945 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89666656 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 1.89666656 |
| 81 | Hyperphosphaturia (HP:0003109) | 1.89370965 |
| 82 | Flat acetabular roof (HP:0003180) | 1.87559327 |
| 83 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87224010 |
| 84 | Pulmonary embolism (HP:0002204) | 1.85915208 |
| 85 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85590612 |
| 86 | Gingival bleeding (HP:0000225) | 1.84988982 |
| 87 | Mucopolysacchariduria (HP:0008155) | 1.83646488 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.83646488 |
| 89 | Abnormality of iron homeostasis (HP:0011031) | 1.83589384 |
| 90 | Delayed CNS myelination (HP:0002188) | 1.82814502 |
| 91 | Gout (HP:0001997) | 1.81400160 |
| 92 | Thrombophlebitis (HP:0004418) | 1.81099054 |
| 93 | Joint swelling (HP:0001386) | 1.80448420 |
| 94 | Congenital sensorineural hearing impairment (HP:0008527) | 1.80423906 |
| 95 | Focal segmental glomerulosclerosis (HP:0000097) | 1.79649362 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.78057844 |
| 97 | Orchitis (HP:0100796) | 1.77843137 |
| 98 | Increased serum ferritin (HP:0003281) | 1.77512239 |
| 99 | Abnormal urine phosphate concentration (HP:0012599) | 1.75286306 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.74764843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.16586517 |
| 2 | ACVR1B | 4.83553449 |
| 3 | RIPK1 | 3.90957620 |
| 4 | MST1R | 3.88831643 |
| 5 | EPHA2 | 3.10491740 |
| 6 | FGFR4 | 2.64474334 |
| 7 | TYK2 | 2.38432003 |
| 8 | PRKG2 | 2.17023162 |
| 9 | TBK1 | 1.93626408 |
| 10 | DDR2 | 1.93479381 |
| 11 | IRAK3 | 1.89921257 |
| 12 | MAP3K3 | 1.87370237 |
| 13 | EPHA3 | 1.66603341 |
| 14 | MATK | 1.59583705 |
| 15 | MAPK15 | 1.59133532 |
| 16 | PIK3CA | 1.58517574 |
| 17 | MAP3K2 | 1.54149892 |
| 18 | EPHB2 | 1.48304480 |
| 19 | MAP4K1 | 1.46640360 |
| 20 | MAP3K11 | 1.45079062 |
| 21 | CDC42BPA | 1.44670868 |
| 22 | TAOK1 | 1.39407157 |
| 23 | RIPK4 | 1.38584601 |
| 24 | EPHB1 | 1.38210737 |
| 25 | STK24 | 1.37849058 |
| 26 | PRPF4B | 1.33030256 |
| 27 | PTK6 | 1.32650041 |
| 28 | MAP3K1 | 1.32003268 |
| 29 | CSK | 1.25515691 |
| 30 | TESK1 | 1.23873310 |
| 31 | MAP3K12 | 1.23317480 |
| 32 | FGFR3 | 1.23215044 |
| 33 | MAP3K14 | 1.21299716 |
| 34 | IKBKE | 1.20900993 |
| 35 | TESK2 | 1.20468943 |
| 36 | MET | 1.19575760 |
| 37 | TRIB3 | 1.11000605 |
| 38 | MYLK | 1.07234143 |
| 39 | MST4 | 1.05054233 |
| 40 | PDPK1 | 1.03775103 |
| 41 | LMTK2 | 1.02325973 |
| 42 | ZAP70 | 0.99360522 |
| 43 | TAOK2 | 0.97872386 |
| 44 | ABL2 | 0.95836546 |
| 45 | TGFBR2 | 0.92049619 |
| 46 | PRKAA2 | 0.88952080 |
| 47 | TXK | 0.88521161 |
| 48 | GRK6 | 0.86726764 |
| 49 | MAP2K2 | 0.85928153 |
| 50 | SIK1 | 0.84116553 |
| 51 | JAK1 | 0.84030510 |
| 52 | MAP2K6 | 0.81635418 |
| 53 | DYRK1B | 0.78253500 |
| 54 | BLK | 0.77720693 |
| 55 | STK39 | 0.77662625 |
| 56 | PDK2 | 0.77544504 |
| 57 | MAPK11 | 0.77243722 |
| 58 | MAP3K10 | 0.76836189 |
| 59 | PRKACG | 0.76482174 |
| 60 | PIM2 | 0.75625731 |
| 61 | GRK7 | 0.72435572 |
| 62 | FER | 0.71814489 |
| 63 | JAK3 | 0.71190871 |
| 64 | NME2 | 0.71115069 |
| 65 | MAPKAPK3 | 0.71033662 |
| 66 | IRAK4 | 0.70878739 |
| 67 | IRAK1 | 0.70548335 |
| 68 | JAK2 | 0.70394446 |
| 69 | NLK | 0.67627140 |
| 70 | ERBB2 | 0.66587110 |
| 71 | PDK1 | 0.66303820 |
| 72 | OXSR1 | 0.61150155 |
| 73 | IKBKB | 0.60605175 |
| 74 | SMG1 | 0.58125213 |
| 75 | CSF1R | 0.56819340 |
| 76 | BMPR2 | 0.56774194 |
| 77 | PDGFRA | 0.53556260 |
| 78 | FGR | 0.51245043 |
| 79 | PAK4 | 0.50412653 |
| 80 | LYN | 0.50040471 |
| 81 | SRC | 0.47658219 |
| 82 | PRKCA | 0.46907737 |
| 83 | KIT | 0.45129864 |
| 84 | PRKCZ | 0.44332446 |
| 85 | CDK6 | 0.44139225 |
| 86 | MAPK7 | 0.43542080 |
| 87 | KDR | 0.40072020 |
| 88 | CHUK | 0.37715089 |
| 89 | IGF1R | 0.37484356 |
| 90 | SYK | 0.36868388 |
| 91 | CAMK2G | 0.36728819 |
| 92 | BMX | 0.36713764 |
| 93 | FYN | 0.34866824 |
| 94 | PRKCD | 0.34088135 |
| 95 | ADRBK2 | 0.33733829 |
| 96 | LCK | 0.33021346 |
| 97 | RET | 0.31028260 |
| 98 | CAMK2D | 0.29420267 |
| 99 | LRRK2 | 0.28416668 |
| 100 | PRKCQ | 0.27622740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.65003515 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.37065024 |
| 3 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.90133360 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78681435 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 2.76168926 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74404968 |
| 7 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.74331304 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.74325837 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.70111074 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69594732 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.54633531 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42594086 |
| 13 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.21047516 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.20969663 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.14691267 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.13065651 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.06397424 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.05870048 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.01980497 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.98706204 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.91824269 |
| 22 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.87041311 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84655200 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.78595514 |
| 25 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.72806807 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.70252517 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63255556 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.60683665 |
| 29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.49944603 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.49740298 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45414432 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.43902600 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40165419 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.23500150 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23323253 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.13670295 |
| 37 | Prion diseases_Homo sapiens_hsa05020 | 1.08640401 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05293600 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.98821734 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.98640317 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96558597 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96039740 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 0.95349709 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94216224 |
| 45 | Pertussis_Homo sapiens_hsa05133 | 0.90333441 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90263032 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.88218668 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87583360 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87496822 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86860599 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.85838884 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84442361 |
| 53 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82902399 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81327878 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80908543 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77610328 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77242465 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72570320 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71592880 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67408089 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.63462972 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62430628 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61363937 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55101786 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54621755 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53221943 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.47926831 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46222634 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45982863 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.45336079 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41310190 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.39050361 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38402657 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37826878 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36094338 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34775919 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31753809 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.31102248 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29842663 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29469910 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29466680 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.28565421 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27779236 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27653623 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.26382323 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26072934 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.26057806 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.23662257 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23270513 |
| 90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22950975 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.22658564 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.20711155 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.20273871 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18445664 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.16514572 |
| 96 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.15961692 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.15224350 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.14562138 |
| 99 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.14231898 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13643343 |

